SCIENTIFIC CONSULTING

Clinical research and drug development are demanding tasks where clinical and preclinical pharmacology, medical expertise, regulatory knowledge, writing skills and biomedical research experience complement each other. Working at CRETA, we have frequently observed how difficult and complex it is to make informed decisions in a busy environment full of responsibilities. When the work load exceeds capacity and time required to consider all issues with due diligence and scientific rigor, an unbiased view might be helpful.

CRETA fully understands these needs and helps to bridge the gaps while delivering results of high quality in time.

PORTFOLIO

» Scientific advice covering objectives, open issues and feasibility of projects
» Support for first-in-human trials
» Conception of clinical phase 0 / I / II studies with emphasis on pharmacokinetics and
   translational investigations (e.g. biomarker or surrogate endpoints)
» Design of stratified studies in precision medicine
» Document architecture for regulatory submissions
» SAP consulting to prospectively structure data sets for dissemination
» Consulting and support during grant submissions (clinical and experimental)

With decades of scientific and writing experience, CRETA has authored and contributed to preclinical and clinical drug development. This is the result of decades of research activity in academia and the pharmaceutical industry.

To have a closer look at the list of publications, please refer to ORCID or visit the researcher profile of Robert Mader.

---